由于安全问题和缺乏证据,澳大利亚首都地区公共卫生服务部门不再提供内分泌硬化疼痛的Pelvic Botox。 Pelvic Botox for endometriosis pain is no longer available in ACT public health services due to safety concerns and lack of evidence.

澳大利亚首都直辖区一些内分泌硬化病人称赞Pelvic Botox注射缓解了剧烈疼痛,但公共卫生服务不再提供这种注射。 Pelvic Botox injections, praised by some endometriosis patients in the Australian Capital Territory for dramatic pain relief, are no longer available through public health services. 尽管传闻成功,但由于未知的风险和科学证据不足,作为预防措施,该程序被停止。 The procedure was halted as a precaution due to unknown risks and insufficient scientific evidence, despite anecdotal success. 唯一负责治疗的医生被命令停止治疗,政府称主要医疗准则没有提供支持。 The only doctor administering the treatment has been ordered to stop, and the government cited lack of support from major medical guidelines. 患者现在正在寻找替代方法,突出显示在管理慢性内分泌硬化疼痛方面持续存在的挑战。 Patients are now seeking alternatives, highlighting ongoing challenges in managing chronic endometriosis pain.